Newomics
Newomics, a US-based biotech firm, innovates personalized healthcare solutions using proprietary silicon-microfluidic-chip technology.
Founded
2011Newomics, a US-based biotech firm, innovates personalized healthcare solutions using proprietary silicon-microfluidic-chip technology.
Newomics, founded in Emeryville, United States, is an early-stage biotechnology company focused on revolutionizing personalized healthcare. The company's core mission is to commercialize innovative and integrative platforms and solutions for the healthcare sector. Utilizing proprietary silicon-microfluidic-chip technology, Newomics offers advanced liquid chromatography-mass spectrometry (LC-MS) systems that provide unprecedented robustness and precision. Their flagship product, the UniESI system, features breakthrough multispray technologies with swappable nanoflow and microflow modules, catering to diverse applications in metabolomics and native mass spectrometry.
Notable figures associated with Newomics include its founders and key investors who have significantly contributed to its growth and innovation. The company has achieved several milestones, including the successful commercialization of its UniESI system and the establishment of strategic partnerships with leading research institutions. Newomics' impact is evident in its contribution to advancing personalized healthcare through cutting-edge technology, offering researchers and clinicians enhanced tools for precise and efficient analysis.
Companies similar to Newomics include NantOmics, CyOmics, Complete Omics and Stellaromics.
Newomics was founded in 2011.
Newomics' headquarters is located in Berkeley, CA, US.
Newomics' most recent funding round was for $7.9M (USD) in December 2020.
As of Dec 1, 2020, Newomics has raised a total of $15.7M (USD).
Newomics has 17 employees as of Feb 5, 2024.
Complete Omics
completeomics.com
